Robert M Grant Selected Research

Emtricitabine (Emtriva)

1/2020	Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
11/2018	Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
1/2018	Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis.
11/2016	Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.
1/2016	The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
1/2015	Streamlining HIV testing for HIV preexposure prophylaxis.
10/2014	Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.
7/2014	HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.
1/2014	Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.
2/2011	Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert M Grant Research Topics

Disease

25	Infections 07/2020 - 07/2002
19	HIV Infections (HIV Infection) 01/2020 - 10/2002
8	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017 - 11/2002
6	Viremia 12/2005 - 01/2002
3	HIV Seropositivity 01/2019 - 01/2018
3	Syphilis 01/2017 - 09/2014
2	Pain (Aches) 01/2018 - 01/2017
2	Body Weight (Weight, Body) 01/2018 - 01/2007
2	Superinfection 07/2004 - 01/2004
1	Substance-Related Disorders (Drug Abuse) 10/2019
1	Binge Drinking 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Lipodystrophy 01/2018
1	Proteinuria 01/2018
1	Injection Site Reaction 01/2017
1	Hepatitis 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Hepatitis B 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2014
1	Hypertension (High Blood Pressure) 03/2014
1	Ulcer 01/2014
1	Gonorrhea 01/2011
1	Nausea 12/2010
1	Meningococcal Infections 05/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2006
1	Brain Diseases (Brain Disorder) 09/2005
1	Disease Progression 01/2004
1	T-Cell Leukemia (Leukemia, T Cell) 01/2003
1	AIDS Dementia Complex 10/2002
1	Opportunistic Infections (Opportunistic Infection) 10/2002

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 10/2019 - 02/2002
14	Tenofovir (Viread)FDA Link 01/2020 - 10/2006
11	Emtricitabine (Emtriva)FDA Link 01/2020 - 10/2006
10	RacivirIBA 01/2020 - 12/2010
5	RNA (Ribonucleic Acid)IBA 02/2018 - 02/2002
4	Antiviral Agents (Antivirals)IBA 07/2020 - 07/2004
4	EnzymesIBA 01/2011 - 08/2006
3	Nucleic AcidsIBA 01/2015 - 04/2003
2	cabotegravirIBA 01/2018 - 01/2017
2	Cocaine (Cocaine HCl)IBA 01/2018 - 06/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2004 - 11/2002
1	tenofovir alafenamideIBA 01/2020
1	AntigensIBA 02/2018
1	bioplexIBA 02/2018
1	Ointments (Pastes)IBA 01/2018
1	cathinoneIBA 01/2018
1	Crack CocaineIBA 01/2018
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2018
1	PowdersIBA 01/2018
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	Biological ProductsIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	IntegrasesIBA 07/2015
1	TabletsIBA 09/2014
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2011
1	Anti-Infective Agents (Microbicides)IBA 05/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Interleukin-2 (IL2)IBA 02/2007
1	CytokinesIBA 02/2007
1	Dehydroepiandrosterone (DHEA)IBA 01/2007
1	Hormones (Hormone)IBA 01/2007
1	Immunoglobulin G (IgG)IBA 11/2006
1	Phosphotransferases (Kinase)IBA 11/2006
1	adefovirIBA 10/2006
1	Lamivudine (Epivir)FDA Link 10/2006
1	Biological FactorsIBA 07/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2004
1	Edetic Acid (EDTA)FDA Link 01/2003
1	BilirubinIBA 01/2003
1	Triglycerides (Triacylglycerol)IBA 01/2003
1	AnticoagulantsIBA 01/2003
1	Hemoglobins (Hemoglobin)IBA 01/2003
1	acid citrate dextroseIBA 01/2003
1	Glucose (Dextrose)FDA LinkGeneric 02/2002

Therapy/Procedure

10	Therapeutics 05/2010 - 01/2002
5	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 10/2002
5	Condoms (Condom) 01/2017 - 05/2010
3	Chemoprevention 06/2016 - 10/2006
1	Injections 01/2017
1	Retention in Care 07/2014